Thumbs down for new testosterone patch to boost women's sex drive

Mar 03, 2009

A new testosterone patch, designed to pep up a woman's flagging sex drive after womb and ovary removal, may not work, and its long term safety is not proven, says Drug and Therapeutics Bulletin (DTB).

Intrinsa was recently licensed in the UK for the treatment of women, who have gone through the menopause as a result of womb and ovary removal, and who are subsequently experiencing a drop in sex drive.

The condition is referred to as hypoactive sexual desire disorder or HSDD for short.

There is some evidence to suggest that a fall in sex drive after the menopause might be linked to low levels of circulating testosterone.

Intrinsa is prescribed for women with HSDD, who are receiving oestrogen replacement therapy. It delivers a daily dose of testosterone from a patch replaced twice weekly and worn continuously on the lower abdomen.

The key trials on testosterone patches have involved highly selective groups of women - excluding, for example, those with various mental or physical conditions that could affect sex drive, says DTB. And in some trials a diagnosis of HSDD was made on the basis of short, unvalidated questionnaires.

There was also a large placebo response in the studies, with significant numbers of women not treated with the patch reporting improved sex drive, which indicates that low hormone levels might not have been the problem, says DTB.

Furthermore, the improvements were small. And the fact that some of the women were already having sex twice or three times a month before they entered the trials, raises questions about whether they really had a poor sex drive in the first place.

The two key trials reported side effect rates of around 75%, mostly attributable to skin reactions at the sites where the patches had been applied. Other common unwanted side effects, occurring in up to one in 10 women, were acne, excess hair (hirsutism), hair loss (alopecia), breast pain, weight gain, insomnia, voice deepening, and migraine. Some of these may persist.

As the trials for Intrinsa lasted a maximum of six months, the long term safety of the patch is not clear, says DTB.

"The published evidence so far is based on highly selected women and only shows small improvements in sexual parameters and large placebo responses," concludes DTB.

"Also the long term safety of the treatment is unknown. Unwanted side effects are common and not always reversible. For all these reasons, we cannot recommend Intrinsa for use in women with sexual dysfunction," it adds.

Source: British Medical Journal

Explore further: AbbVie shares sink after $21 bn deal for Pharmacyclics

add to favorites email to friend print save as pdf

Related Stories

Perfume could be the riskiest gift you'll ever buy

Feb 16, 2015

When it comes to making careful plans to impress that significant other, certain things can seem like musts. Classy restaurant – check. Romantic atmosphere – check. Best suit or little black dress – ...

Sex, genes, the Y chromosome and the future of men

Nov 14, 2014

The Y chromosome, that little chain of genes that determines the sex of humans, is not as tough as you might think. In fact, if we look at the Y chromosome over the course of our evolution we've seen it shrink ...

Recommended for you

US must respond to global health outbreaks, say bioethicists

15 hours ago

Last summer, West Africa fell into the grip of a deadly outbreak of Ebola that has thus far taken the lives of more than 9,500 people. The fear swept up by the epidemic quickly jumped across the Atlantic and landed in the ...

Uganda on defensive over medical 'brain drain' uproar

Mar 03, 2015

Uganda's government on Tuesday hit back at mounting criticism of plans to 'export' over 200 health workers to the Caribbean, insisting it was only seeking to regulate an existing labour market and prevent abuses.

Seth Mnookin on vaccination and public health

Mar 02, 2015

Seth Mnookin, an assistant professor of science writing and associate director of MIT's Graduate Program in Science Writing, is the author of "The Panic Virus: The True Story Behind the Vaccine-Autism Controversy" ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

superhuman
not rated yet Mar 03, 2009
hypoactive sexual desire disorder


Low sex drive after menopause is NOT a disorder it is perfectly normal and expected outcome.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.